Organigram Global (OGI) Cash & Current Investments (2018 - 2026)

Organigram Global (OGI) posted quarterly Cash & Current Investments of -$33.1 million for Q1 2026, up 31.53% year-on-year from -$25.1 million in Q1 2025, and up 1.88% on a QoQ basis from -$33.7 million in Q4 2025.

Organigram Global (OGI) Cash & Current Investments (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Cash & Current Investments for 9 consecutive years, with -$33.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash & Current Investments rose 31.53% year-over-year to -$33.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.1 million (up 49.71% YoY) and the FY2025 annual result came in at -$33.7 million, changed N/A from the prior year.
  • Cash & Current Investments rose to -$33.1 million in Q1 2026 per OGI's latest filing, from -$33.7 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for OGI reached as high as $97.2 million in Q3 2024 and fell as low as -$48.3 million in Q1 2025.
  • A 5-year average of $5.6 million and a median of $1.7 million in 2022 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2024 — Cash & Current Investments jumped 151.78% — and 2025, when it sank 93.1%.
  • Year by year, Cash & Current Investments stood at $20.8 million in 2022, then jumped by 85.38% to $38.6 million in 2023, then slumped by 145.22% to -$17.5 million in 2024, then plunged by 93.1% to -$33.7 million in 2025, then rose by 1.88% to -$33.1 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered -$33.1 million, -$33.7 million, and $21.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 428.00 Mn
10 Organigram Global 121.15 Mn 154.23 Mn 28.97 Mn -33.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -33.08 Mn
Dec 31, 2025 -33.71 Mn
Sep 30, 2025 21.09 Mn
Mar 31, 2025 -48.31 Mn
Dec 31, 2024 -17.46 Mn
Sep 30, 2024 97.21 Mn
Sep 30, 2023 38.61 Mn
Aug 31, 2022 20.83 Mn
Nov 30, 2021 69.01 Mn
Aug 31, 2021 183.56 Mn
May 31, 2021 169.16 Mn
Feb 28, 2021 71.12 Mn
Nov 30, 2020 133.90 Mn
Aug 31, 2020 56.11 Mn
May 31, 2020 32.02 Mn
Feb 29, 2020 41.24 Mn
Aug 31, 2019 287,429.99
Aug 31, 2018 55.06 Mn